In 2022, 81,806 opioid-involved overdose deaths were reported in the United States, more than in any previous year. Medications for opioid use disorder (OUD), particularly buprenorphine and methadone, substantially reduce overdose-related and overall mortality. However, only a small proportion of persons with OUD receive these medications. Data from the 2022 National Survey on Drug Use and Health were applied to a cascade of care framework to estimate and characterize U.S. adult populations who need OUD treatment, receive any OUD treatment, and receive medications for OUD. In 2022, 3.7% of U.S. adults aged ≥18 years needed OUD treatment. Among these, only 25.1% received medications for OUD. Most adults who needed OUD treatment either did not perceive that they needed it (42.7%) or received OUD treatment without medications for OUD (30.0%). Compared with non-Hispanic Black or African American and Hispanic or Latino adults, higher percentages of non-Hispanic White adults received any OUD treatment. Higher percentages of men and adults aged 35-49 years received medications for OUD than did women and younger or older adults. Expanded communication about the effectiveness of medications for OUD is needed. Increased efforts to engage persons with OUD in treatment that includes medications are essential. Clinicians and other treatment providers should offer or arrange evidence-based treatment, including medications, for patients with OUD. Pharmacists and payors can work to make these medications available without delays.

中文翻译：

---

阿片类药物使用障碍的治疗：人口估计 - 美国，2022 年。


2022 年，美国报告了 81,806 例因阿片类药物过量死亡的病例，比以往任何一年都要多。治疗阿片类药物使用障碍 (OUD) 的药物，特别是丁丙诺啡和美沙酮，可大大降低与药物过量相关的死亡率和总体死亡率。然而，只有一小部分 OUD 患者接受这些药物治疗。 2022 年全国药物使用和健康调查的数据被应用于一系列护理框架，以估计和描述需要 OUD 治疗、接受任何 OUD 治疗以及接受 OUD 药物治疗的美国成年人口。到 2022 年，3.7% 的 18 岁以上美国成年人需要 OUD 治疗。其中，只有 25.1% 的人接受了 OUD 药物治疗。大多数需要 OUD 治疗的成年人要么不认为自己需要它 (42.7%)，要么在没有服用 OUD 药物的情况下接受 OUD 治疗 (30.0%)。与非西班牙裔黑人或非裔美国人以及西班牙裔或拉丁裔成年人相比，非西班牙裔白人成年人接受 OUD 治疗的比例更高。 35-49 岁的男性和成年人接受 OUD 药物治疗的比例高于女性和年轻人或老年人。需要就 OUD 药物的有效性进行广泛的沟通。加大努力让 OUD 患者接受包括药物在内的治疗至关重要。临床医生和其他治疗提供者应为 OUD 患者提供或安排循证治疗，包括药物治疗。药剂师和付款人可以努力立即提供这些药物。